The emergence of novel psychoactive substances introduces a unique challenge for researchers and policymakers alike. Among these, 2-FDCK has gained prominence as a potent dissociative agent with unknown pharmacological properties. Early studies suggest that 2-FDCK may elicit similar effects to other dissociatives, such as ketamine, but its precise